A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge by Stylianou, E, Pinpathomrat, N, Sampson, O, Richard, A, Korompis, M, McShane, H

Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. by Prevo, R, Deutsch, E, Sampson, O, Diplexcito, J, Cengel, K, Harper, J, O'Neill, P, Mckenna, W, Patel, S, Bernhard, E

The unusual finding of peripheral lymphadenopathy among confirmed Lassa fever patients in Nigeria by Sampson O Owhin, Chukuyem Abejegah, Lanre O Olatunde, Nelson A Adedosu, Olufemi O Ayodeji, Timothy R Folorunso, Joachim Azegbeobor, Peter E Akhideno, George O Akpede, Joseph A Ayeyemi, Oyebanji Z Olowosusi, Cyril Erameh, Liasu A Ahmed

Get full text

Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members by Jay, C, Adland, E, Csala, A, Dold, C, Edmans, M, Hackstein, C-P, Jamsen, A, Lim, N, Longet, S, Ogbe, A, Sampson, O, Skelly, D, Spiller, OB, Stafford, L, Thompson, CP, Turtle, L, Barnes, E, Dunachie, S, Carroll, M, Klenerman, P, Conlon, C, Goulder, P, Jones, LC

Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients by Youngs, J, Provine, NM, Lim, N, Sharpe, HR, Amini, A, Chen, Y-L, Luo, J, Edmans, MD, Zacharopoulou, P, Chen, W, Sampson, O, Paton, R, Hurt, WJ, Duncan, DA, McNaughton, AL, Miao, VN, Leaver, S, Wyncoll, DLA, Ball, J, Hopkins, P, Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team, Skelly, DT, Barnes, E, Dunachie, S, Ogg, G, Lambe, T, Pavord, I, Shalek, AK, Thompson, CP, Xue, L, Macallan, DC, Goulder, P, Klenerman, P, Bicanic, T

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 by Thompson, CP, Grayson, N, Paton, R, Bolton, JS, Lourenco, J, Penman, B, Lee, LN, Odon, V, Mongkolsapaya, J, Chinnakannan, S, Dejnirattisai, W, Edmans, M, Fyfe, A, Imlach, C, Kooblall, K, Lim, N, Liu, C, Lopez-Camacho, C, McInally, C-A, McNaughton, AL, Ramamurthy, N, Ratcliff, J, Supasa, P, Wang, B, Mentzer, AJ, Turner, M, Sampson, O, Semple, C, Baillie, JK, ISARIC4C Investigators, Harvala, H, Screaton, G, Temperton, N, Klenerman, P, Jarvis, L, Gupta, S, Simmonds, P

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. by Ogbe, A, Kronsteiner, B, Skelly, DT, Pace, M, Brown, A, Adland, E, Adair, K, Akhter, HD, Ali, M, Ali, S-E, Angyal, A, Ansari, MA, Arancibia-Cárcamo, CV, Brown, H, Chinnakannan, S, Conlon, C, de Lara, C, de Silva, T, Dold, C, Dong, T, Donnison, T, Eyre, D, Flaxman, A, Fletcher, H, Gardner, J, Grist, JT, Hackstein, C-P, Jaruthamsophon, K, Jeffery, K, Lambe, T, Lee, L, Li, W, Lim, N, Matthews, PC, Mentzer, AJ, Moore, SC, Naisbitt, DJ, Ogese, M, Ogg, G, Openshaw, P, Pirmohamed, M, Pollard, AJ, Ramamurthy, N, Rongkard, P, Rowland-Jones, S, Sampson, O, Screaton, G, Sette, A, Stafford, L, Thompson, C, Klenerman, P, Frater, J, Dunachie, S